Capstone Investment Advisors
CO

Capstone Investment Advisors’s Global Cord Blood Corporation CO Stock Holding History

Capstone Investment Advisors’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,345
Closed -$126K – 740
2017
Q3 		$126K Buy
+11,345
New +$133K ﹤0.01% 502
2017
Q2 		– Sell
-112,695
Closed -$750K – 1068
2017
Q1 		$750K Buy
+112,695
New +$668K 0.02% 495

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Capstone Investment Advisors's CO Position: Q4 2017 in Review

Capstone Investment Advisors sold out of Global Cord Blood Corporation (CO) in Q4 2017, closing a stake of 11,345 shares — an estimated $126K sold.

Capstone Investment Advisors first reported a position in CO in Q1 2017 and held it in 2 quarters. The position peaked at $750K in Q1 2017. 50 funds tracked by Wall St. Rank hold CO as of Q4 2017.

  • Capstone Investment Advisors reported no remaining Global Cord Blood Corporation position as of Q4 2017 after selling out during the quarter.
  • Capstone Investment Advisors sold 11,345 Global Cord Blood Corporation shares in Q4 2017, an estimated $126K.
  • Capstone Investment Advisors first reported a position in Global Cord Blood Corporation in Q1 2017 and held it in 2 quarters.
  • Capstone Investment Advisors's Global Cord Blood Corporation position peaked at $750K in Q1 2017.
  • 50 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2017.

Based on Capstone Investment Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.